The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Miscellaneous Antimalarials Market Research Report 2025
Synopsis
Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. The best way to prevent malaria is by taking antimalarial drugs prophylactically prior to entering an endemic area.
The global Miscellaneous Antimalarials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Miscellaneous Antimalarials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Miscellaneous Antimalarials.
Report Scope
The Miscellaneous Antimalarials market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Miscellaneous Antimalarials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Miscellaneous Antimalarials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Norvatis
Teva Pharmaceutical Industries
Bayer AG.
GlaxoSmithKline Plc.
Ipca Laboratories Ltd.
Milan Pharmaceuticals
Paso Laboratories
Glenmark Pharmaceutical Inc.
Zydus Cadila
Segment by Type
Doxycyline
Pyrimethamine
Halofantrine
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Miscellaneous Antimalarials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Miscellaneous Antimalarials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. The best way to prevent malaria is by taking antimalarial drugs prophylactically prior to entering an endemic area.
The global Miscellaneous Antimalarials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Miscellaneous Antimalarials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Miscellaneous Antimalarials.
Report Scope
The Miscellaneous Antimalarials market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Miscellaneous Antimalarials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Miscellaneous Antimalarials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Norvatis
Teva Pharmaceutical Industries
Bayer AG.
GlaxoSmithKline Plc.
Ipca Laboratories Ltd.
Milan Pharmaceuticals
Paso Laboratories
Glenmark Pharmaceutical Inc.
Zydus Cadila
Segment by Type
Doxycyline
Pyrimethamine
Halofantrine
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Miscellaneous Antimalarials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Miscellaneous Antimalarials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Miscellaneous Antimalarials Market Overview
1.1 Product Overview and Scope of Miscellaneous Antimalarials
1.2 Miscellaneous Antimalarials Segment by Type
1.2.1 Global Miscellaneous Antimalarials Market Value Comparison by Type (2024-2030)
1.2.2 Doxycyline
1.2.3 Pyrimethamine
1.2.4 Halofantrine
1.3 Miscellaneous Antimalarials Segment by Application
1.3.1 Global Miscellaneous Antimalarials Market Value by Application: (2024-2030)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Miscellaneous Antimalarials Market Size Estimates and Forecasts
1.4.1 Global Miscellaneous Antimalarials Revenue 2019-2030
1.4.2 Global Miscellaneous Antimalarials Sales 2019-2030
1.4.3 Global Miscellaneous Antimalarials Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Miscellaneous Antimalarials Market Competition by Manufacturers
2.1 Global Miscellaneous Antimalarials Sales Market Share by Manufacturers (2019-2024)
2.2 Global Miscellaneous Antimalarials Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Miscellaneous Antimalarials Average Price by Manufacturers (2019-2024)
2.4 Global Miscellaneous Antimalarials Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Miscellaneous Antimalarials, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Miscellaneous Antimalarials, Product Type & Application
2.7 Miscellaneous Antimalarials Market Competitive Situation and Trends
2.7.1 Miscellaneous Antimalarials Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Miscellaneous Antimalarials Players Market Share by Revenue
2.7.3 Global Miscellaneous Antimalarials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Miscellaneous Antimalarials Retrospective Market Scenario by Region
3.1 Global Miscellaneous Antimalarials Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Miscellaneous Antimalarials Global Miscellaneous Antimalarials Sales by Region: 2019-2030
3.2.1 Global Miscellaneous Antimalarials Sales by Region: 2019-2024
3.2.2 Global Miscellaneous Antimalarials Sales by Region: 2025-2030
3.3 Global Miscellaneous Antimalarials Global Miscellaneous Antimalarials Revenue by Region: 2019-2030
3.3.1 Global Miscellaneous Antimalarials Revenue by Region: 2019-2024
3.3.2 Global Miscellaneous Antimalarials Revenue by Region: 2025-2030
3.4 North America Miscellaneous Antimalarials Market Facts & Figures by Country
3.4.1 North America Miscellaneous Antimalarials Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Miscellaneous Antimalarials Sales by Country (2019-2030)
3.4.3 North America Miscellaneous Antimalarials Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Miscellaneous Antimalarials Market Facts & Figures by Country
3.5.1 Europe Miscellaneous Antimalarials Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Miscellaneous Antimalarials Sales by Country (2019-2030)
3.5.3 Europe Miscellaneous Antimalarials Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Miscellaneous Antimalarials Market Facts & Figures by Country
3.6.1 Asia Pacific Miscellaneous Antimalarials Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Miscellaneous Antimalarials Sales by Country (2019-2030)
3.6.3 Asia Pacific Miscellaneous Antimalarials Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Miscellaneous Antimalarials Market Facts & Figures by Country
3.7.1 Latin America Miscellaneous Antimalarials Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Miscellaneous Antimalarials Sales by Country (2019-2030)
3.7.3 Latin America Miscellaneous Antimalarials Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Miscellaneous Antimalarials Market Facts & Figures by Country
3.8.1 Middle East and Africa Miscellaneous Antimalarials Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Miscellaneous Antimalarials Sales by Country (2019-2030)
3.8.3 Middle East and Africa Miscellaneous Antimalarials Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Miscellaneous Antimalarials Sales by Type (2019-2030)
4.1.1 Global Miscellaneous Antimalarials Sales by Type (2019-2024)
4.1.2 Global Miscellaneous Antimalarials Sales by Type (2025-2030)
4.1.3 Global Miscellaneous Antimalarials Sales Market Share by Type (2019-2030)
4.2 Global Miscellaneous Antimalarials Revenue by Type (2019-2030)
4.2.1 Global Miscellaneous Antimalarials Revenue by Type (2019-2024)
4.2.2 Global Miscellaneous Antimalarials Revenue by Type (2025-2030)
4.2.3 Global Miscellaneous Antimalarials Revenue Market Share by Type (2019-2030)
4.3 Global Miscellaneous Antimalarials Price by Type (2019-2030)
5 Segment by Application
5.1 Global Miscellaneous Antimalarials Sales by Application (2019-2030)
5.1.1 Global Miscellaneous Antimalarials Sales by Application (2019-2024)
5.1.2 Global Miscellaneous Antimalarials Sales by Application (2025-2030)
5.1.3 Global Miscellaneous Antimalarials Sales Market Share by Application (2019-2030)
5.2 Global Miscellaneous Antimalarials Revenue by Application (2019-2030)
5.2.1 Global Miscellaneous Antimalarials Revenue by Application (2019-2024)
5.2.2 Global Miscellaneous Antimalarials Revenue by Application (2025-2030)
5.2.3 Global Miscellaneous Antimalarials Revenue Market Share by Application (2019-2030)
5.3 Global Miscellaneous Antimalarials Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Norvatis
6.1.1 Norvatis Corporation Information
6.1.2 Norvatis Description and Business Overview
6.1.3 Norvatis Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Norvatis Miscellaneous Antimalarials Product Portfolio
6.1.5 Norvatis Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Corporation Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Industries Miscellaneous Antimalarials Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 Bayer AG.
6.3.1 Bayer AG. Corporation Information
6.3.2 Bayer AG. Description and Business Overview
6.3.3 Bayer AG. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer AG. Miscellaneous Antimalarials Product Portfolio
6.3.5 Bayer AG. Recent Developments/Updates
6.4 GlaxoSmithKline Plc.
6.4.1 GlaxoSmithKline Plc. Corporation Information
6.4.2 GlaxoSmithKline Plc. Description and Business Overview
6.4.3 GlaxoSmithKline Plc. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Plc. Miscellaneous Antimalarials Product Portfolio
6.4.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.5 Ipca Laboratories Ltd.
6.5.1 Ipca Laboratories Ltd. Corporation Information
6.5.2 Ipca Laboratories Ltd. Description and Business Overview
6.5.3 Ipca Laboratories Ltd. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ipca Laboratories Ltd. Miscellaneous Antimalarials Product Portfolio
6.5.5 Ipca Laboratories Ltd. Recent Developments/Updates
6.6 Milan Pharmaceuticals
6.6.1 Milan Pharmaceuticals Corporation Information
6.6.2 Milan Pharmaceuticals Description and Business Overview
6.6.3 Milan Pharmaceuticals Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Milan Pharmaceuticals Miscellaneous Antimalarials Product Portfolio
6.6.5 Milan Pharmaceuticals Recent Developments/Updates
6.7 Paso Laboratories
6.6.1 Paso Laboratories Corporation Information
6.6.2 Paso Laboratories Description and Business Overview
6.6.3 Paso Laboratories Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Paso Laboratories Miscellaneous Antimalarials Product Portfolio
6.7.5 Paso Laboratories Recent Developments/Updates
6.8 Glenmark Pharmaceutical Inc.
6.8.1 Glenmark Pharmaceutical Inc. Corporation Information
6.8.2 Glenmark Pharmaceutical Inc. Description and Business Overview
6.8.3 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Product Portfolio
6.8.5 Glenmark Pharmaceutical Inc. Recent Developments/Updates
6.9 Zydus Cadila
6.9.1 Zydus Cadila Corporation Information
6.9.2 Zydus Cadila Description and Business Overview
6.9.3 Zydus Cadila Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zydus Cadila Miscellaneous Antimalarials Product Portfolio
6.9.5 Zydus Cadila Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Miscellaneous Antimalarials Industry Chain Analysis
7.2 Miscellaneous Antimalarials Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Miscellaneous Antimalarials Production Mode & Process
7.4 Miscellaneous Antimalarials Sales and Marketing
7.4.1 Miscellaneous Antimalarials Sales Channels
7.4.2 Miscellaneous Antimalarials Distributors
7.5 Miscellaneous Antimalarials Customers
8 Miscellaneous Antimalarials Market Dynamics
8.1 Miscellaneous Antimalarials Industry Trends
8.2 Miscellaneous Antimalarials Market Drivers
8.3 Miscellaneous Antimalarials Market Challenges
8.4 Miscellaneous Antimalarials Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Miscellaneous Antimalarials Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Miscellaneous Antimalarials Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Miscellaneous Antimalarials Market Competitive Situation by Manufacturers in 2023
Table 4. Global Miscellaneous Antimalarials Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Miscellaneous Antimalarials Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Miscellaneous Antimalarials Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Miscellaneous Antimalarials Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Miscellaneous Antimalarials Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Miscellaneous Antimalarials, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Miscellaneous Antimalarials, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Miscellaneous Antimalarials, Product Type & Application
Table 12. Global Key Manufacturers of Miscellaneous Antimalarials, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Miscellaneous Antimalarials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Miscellaneous Antimalarials as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Miscellaneous Antimalarials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Miscellaneous Antimalarials Sales by Region (2019-2024) & (Tons)
Table 18. Global Miscellaneous Antimalarials Sales Market Share by Region (2019-2024)
Table 19. Global Miscellaneous Antimalarials Sales by Region (2025-2030) & (Tons)
Table 20. Global Miscellaneous Antimalarials Sales Market Share by Region (2025-2030)
Table 21. Global Miscellaneous Antimalarials Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Miscellaneous Antimalarials Revenue Market Share by Region (2019-2024)
Table 23. Global Miscellaneous Antimalarials Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Miscellaneous Antimalarials Revenue Market Share by Region (2025-2030)
Table 25. North America Miscellaneous Antimalarials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Miscellaneous Antimalarials Sales by Country (2019-2024) & (Tons)
Table 27. North America Miscellaneous Antimalarials Sales by Country (2025-2030) & (Tons)
Table 28. North America Miscellaneous Antimalarials Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Miscellaneous Antimalarials Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Miscellaneous Antimalarials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Miscellaneous Antimalarials Sales by Country (2019-2024) & (Tons)
Table 32. Europe Miscellaneous Antimalarials Sales by Country (2025-2030) & (Tons)
Table 33. Europe Miscellaneous Antimalarials Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Miscellaneous Antimalarials Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Miscellaneous Antimalarials Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Miscellaneous Antimalarials Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Miscellaneous Antimalarials Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Miscellaneous Antimalarials Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Miscellaneous Antimalarials Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Miscellaneous Antimalarials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Miscellaneous Antimalarials Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Miscellaneous Antimalarials Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Miscellaneous Antimalarials Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Miscellaneous Antimalarials Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Miscellaneous Antimalarials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Miscellaneous Antimalarials Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Miscellaneous Antimalarials Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Miscellaneous Antimalarials Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Miscellaneous Antimalarials Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Miscellaneous Antimalarials Sales (Tons) by Type (2019-2024)
Table 51. Global Miscellaneous Antimalarials Sales (Tons) by Type (2025-2030)
Table 52. Global Miscellaneous Antimalarials Sales Market Share by Type (2019-2024)
Table 53. Global Miscellaneous Antimalarials Sales Market Share by Type (2025-2030)
Table 54. Global Miscellaneous Antimalarials Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Miscellaneous Antimalarials Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Miscellaneous Antimalarials Revenue Market Share by Type (2019-2024)
Table 57. Global Miscellaneous Antimalarials Revenue Market Share by Type (2025-2030)
Table 58. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2019-2024)
Table 59. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2025-2030)
Table 60. Global Miscellaneous Antimalarials Sales (Tons) by Application (2019-2024)
Table 61. Global Miscellaneous Antimalarials Sales (Tons) by Application (2025-2030)
Table 62. Global Miscellaneous Antimalarials Sales Market Share by Application (2019-2024)
Table 63. Global Miscellaneous Antimalarials Sales Market Share by Application (2025-2030)
Table 64. Global Miscellaneous Antimalarials Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Miscellaneous Antimalarials Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Miscellaneous Antimalarials Revenue Market Share by Application (2019-2024)
Table 67. Global Miscellaneous Antimalarials Revenue Market Share by Application (2025-2030)
Table 68. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2019-2024)
Table 69. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2025-2030)
Table 70. Norvatis Corporation Information
Table 71. Norvatis Description and Business Overview
Table 72. Norvatis Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Norvatis Miscellaneous Antimalarials Product
Table 74. Norvatis Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Corporation Information
Table 76. Teva Pharmaceutical Industries Description and Business Overview
Table 77. Teva Pharmaceutical Industries Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceutical Industries Miscellaneous Antimalarials Product
Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
Table 80. Bayer AG. Corporation Information
Table 81. Bayer AG. Description and Business Overview
Table 82. Bayer AG. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Bayer AG. Miscellaneous Antimalarials Product
Table 84. Bayer AG. Recent Developments/Updates
Table 85. GlaxoSmithKline Plc. Corporation Information
Table 86. GlaxoSmithKline Plc. Description and Business Overview
Table 87. GlaxoSmithKline Plc. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Plc. Miscellaneous Antimalarials Product
Table 89. GlaxoSmithKline Plc. Recent Developments/Updates
Table 90. Ipca Laboratories Ltd. Corporation Information
Table 91. Ipca Laboratories Ltd. Description and Business Overview
Table 92. Ipca Laboratories Ltd. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Ipca Laboratories Ltd. Miscellaneous Antimalarials Product
Table 94. Ipca Laboratories Ltd. Recent Developments/Updates
Table 95. Milan Pharmaceuticals Corporation Information
Table 96. Milan Pharmaceuticals Description and Business Overview
Table 97. Milan Pharmaceuticals Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Milan Pharmaceuticals Miscellaneous Antimalarials Product
Table 99. Milan Pharmaceuticals Recent Developments/Updates
Table 100. Paso Laboratories Corporation Information
Table 101. Paso Laboratories Description and Business Overview
Table 102. Paso Laboratories Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Paso Laboratories Miscellaneous Antimalarials Product
Table 104. Paso Laboratories Recent Developments/Updates
Table 105. Glenmark Pharmaceutical Inc. Corporation Information
Table 106. Glenmark Pharmaceutical Inc. Description and Business Overview
Table 107. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Product
Table 109. Glenmark Pharmaceutical Inc. Recent Developments/Updates
Table 110. Zydus Cadila Corporation Information
Table 111. Zydus Cadila Description and Business Overview
Table 112. Zydus Cadila Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Zydus Cadila Miscellaneous Antimalarials Product
Table 114. Zydus Cadila Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Miscellaneous Antimalarials Distributors List
Table 118. Miscellaneous Antimalarials Customers List
Table 119. Miscellaneous Antimalarials Market Trends
Table 120. Miscellaneous Antimalarials Market Drivers
Table 121. Miscellaneous Antimalarials Market Challenges
Table 122. Miscellaneous Antimalarials Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Miscellaneous Antimalarials
Figure 2. Global Miscellaneous Antimalarials Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Miscellaneous Antimalarials Market Share by Type in 2023 & 2030
Figure 4. Doxycyline Product Picture
Figure 5. Pyrimethamine Product Picture
Figure 6. Halofantrine Product Picture
Figure 7. Global Miscellaneous Antimalarials Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Miscellaneous Antimalarials Market Share by Application in 2023 & 2030
Figure 9. Prevention
Figure 10. Treatment
Figure 11. Global Miscellaneous Antimalarials Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Miscellaneous Antimalarials Market Size (2019-2030) & (US$ Million)
Figure 13. Global Miscellaneous Antimalarials Sales (2019-2030) & (Tons)
Figure 14. Global Miscellaneous Antimalarials Average Price (US$/Kg) & (2019-2030)
Figure 15. Miscellaneous Antimalarials Report Years Considered
Figure 16. Miscellaneous Antimalarials Sales Share by Manufacturers in 2023
Figure 17. Global Miscellaneous Antimalarials Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Miscellaneous Antimalarials Players: Market Share by Revenue in 2023
Figure 19. Miscellaneous Antimalarials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Miscellaneous Antimalarials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Miscellaneous Antimalarials Sales Market Share by Country (2019-2030)
Figure 22. North America Miscellaneous Antimalarials Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Miscellaneous Antimalarials Sales Market Share by Country (2019-2030)
Figure 26. Europe Miscellaneous Antimalarials Revenue Market Share by Country (2019-2030)
Figure 27. Germany Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Miscellaneous Antimalarials Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Miscellaneous Antimalarials Revenue Market Share by Region (2019-2030)
Figure 34. China Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Miscellaneous Antimalarials Sales Market Share by Country (2019-2030)
Figure 45. Latin America Miscellaneous Antimalarials Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Miscellaneous Antimalarials Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Miscellaneous Antimalarials Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Miscellaneous Antimalarials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Miscellaneous Antimalarials by Type (2019-2030)
Figure 55. Global Revenue Market Share of Miscellaneous Antimalarials by Type (2019-2030)
Figure 56. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Miscellaneous Antimalarials by Application (2019-2030)
Figure 58. Global Revenue Market Share of Miscellaneous Antimalarials by Application (2019-2030)
Figure 59. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2019-2030)
Figure 60. Miscellaneous Antimalarials Value Chain
Figure 61. Miscellaneous Antimalarials Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
